ferropharma group

Rocuronium for Bolivia

The year 2022 has just started and one of the first news that reached us was that we won one of the biggest tenders with Rocuronium 10mg/ml in Bolivia! Our partner has repeatedly proven to be one of the strongest players in Latin America for drug marketing and availability.

Rocuronium is one of the muscle relaxants needed for treatment of patients in emergency rescue interventions, surgery and intensive care units. And during the Covid-19 pandemic its worldwide demand rose, as it is one of the medicines needed for intubation of patients with a critical progression of the disease.

In great cooperation all available suppliers are trying to make the drug available around the globe. We see it all the more as a success that our EU-approved drug, which is therefore produced in an EU-supervised manufacturing facility, won the tender in Bolivia. In accordance with the motto of our brand EMELEMA(R) (Making Latest Medicine Available), we have proven that what is considered among the most demanding levels of quality in documentation, production and logistics is not in competition with local commercial conditions.

And we are pleased about the recognition of the Bolivian authorities, who have thus cemented the standard for product safety and efficacy in Bolivia.